Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may ...

Increasing blood vitamin D levels with high-dose supplementation shows promise for people with first symptoms suggestive of ...

In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective coating around nerves, which gets damaged in multiple sclerosis (MS) causing ...

A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

Nebraska Medicine has become the first medical center in the world to use allogeneic CAR T-cell therapy to treat multiple ...

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

MILAN -- A path to a cure for multiple sclerosis (MS) may be on the horizon, a top MS researcher suggested. The field faces a great opportunity to advance from suppressing the disease to curing it, ...

Ryan Haumschild, PharmD, MS, MBA: One of the things I see is, pharmacists play an important role in treatment recommendations and follow-up as well. A lot of times when you’re counseling a patient or ...

Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...

Initiating treatment for multiple sclerosis (MS) within 6 months of the first symptoms is associated with a significantly lower risk for severe disability one decade later, a new study suggests.